PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Beneish M-Score: -2.82 (As of Jun. 28, 2026)


ISX:DVLA PT Darya-Varia Laboratoria Tbk ISX:DVLA
73 GF Score
Price Rp1,595.00
GF Value Rp1,840.45
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PT Darya-Varia Laboratoria Tbk Beneish M-Score?

PT Darya-Varia Laboratoria Tbk ISX:DVLA 73 Beneish M-Score is -2.82 as of Jun. 28, 2026. GuruFocus rates ISX:DVLA with a GF Score™ of 73/100 and a GF Value™ of Rp1,840.45 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 908 Drug Manufacturers companies, PT Darya-Varia Laboratoria Tbk ranks better than 75.77% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.82 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for PT Darya-Varia Laboratoria Tbk's Beneish M-Score or its related term are showing as below:

ISX:DVLA' s Beneish M-Score Range Over the Past 10 Years
Min: -3.49   Med: -2.4   Max: -1.4
Current: -2.82

During the past 13 years, the highest Beneish M-Score of PT Darya-Varia Laboratoria Tbk was -1.40. The lowest was -3.49. And the median was -2.40.


PT Darya-Varia Laboratoria Tbk Beneish M-Score Historical Data

* Premium members only.

The historical data trend for PT Darya-Varia Laboratoria Tbk's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Darya-Varia Laboratoria Tbk Beneish M-Score Chart

PT Darya-Varia Laboratoria Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.49 -1.83 -2.10 -2.85 -2.53

PT Darya-Varia Laboratoria Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.75 -3.18 -2.51 -2.53 -2.82

ISX:DVLA vs ZTS, UTHR, VTRS: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PT Darya-Varia Laboratoria Tbk's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Darya-Varia Laboratoria Tbk Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Darya-Varia Laboratoria Tbk's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where PT Darya-Varia Laboratoria Tbk's Beneish M-Score falls into.


ISX:DVLA
73GF Score
PT Darya-Varia Laboratoria Tbk ISX:DVLA
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Darya-Varia Laboratoria Tbk Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of PT Darya-Varia Laboratoria Tbk for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8901+0.528 * 1.0103+0.404 * 0.9538+0.892 * 1.087+0.115 * 0.9597
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0798+4.679 * -0.057321-0.327 * 1.0496
=-2.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was Rp840,449 Mil.
Revenue was 594799.409 + 603555.249 + 542093.664 + 541806.854 = Rp2,282,255 Mil.
Gross Profit was 301377.724 + 326813.947 + 293128.669 + 284439.241 = Rp1,205,760 Mil.
Total Current Assets was Rp1,831,262 Mil.
Total Assets was Rp2,516,208 Mil.
Property, Plant and Equipment(Net PPE) was Rp496,082 Mil.
Depreciation, Depletion and Amortization(DDA) was Rp41,885 Mil.
Selling, General, & Admin. Expense(SGA) was Rp627,246 Mil.
Total Current Liabilities was Rp780,931 Mil.
Long-Term Debt & Capital Lease Obligation was Rp0 Mil.
Net Income was 55308.691 + -383.279 + 42891.35 + 42572.022 = Rp140,389 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = Rp0 Mil.
Cash Flow from Operations was 143989.129 + 9379.385 + 37225.287 + 94025.596 = Rp284,619 Mil.
Total Receivables was Rp868,612 Mil.
Revenue was 544293.044 + 494939.507 + 505446.01 + 554929.101 = Rp2,099,608 Mil.
Gross Profit was 308359.127 + 259169.427 + 272493.208 + 280712.324 = Rp1,120,734 Mil.
Total Current Assets was Rp1,741,067 Mil.
Total Assets was Rp2,390,356 Mil.
Property, Plant and Equipment(Net PPE) was Rp461,180 Mil.
Depreciation, Depletion and Amortization(DDA) was Rp37,242 Mil.
Selling, General, & Admin. Expense(SGA) was Rp534,409 Mil.
Total Current Liabilities was Rp706,357 Mil.
Long-Term Debt & Capital Lease Obligation was Rp481 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(840448.761 / 2282255.176) / (868611.523 / 2099607.662)
=0.368254 / 0.413702
=0.8901

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1120734.086 / 2099607.662) / (1205759.581 / 2282255.176)
=0.533783 / 0.528319
=1.0103

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1831261.822 + 496081.944) / 2516208.197) / (1 - (1741066.936 + 461179.875) / 2390355.519)
=0.075059 / 0.078695
=0.9538

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2282255.176 / 2099607.662
=1.087

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(37241.966 / (37241.966 + 461179.875)) / (41884.692 / (41884.692 + 496081.944))
=0.07472 / 0.077857
=0.9597

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(627245.947 / 2282255.176) / (534408.784 / 2099607.662)
=0.274836 / 0.254528
=1.0798

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 780931.446) / 2516208.197) / ((480.859 + 706356.981) / 2390355.519)
=0.31036 / 0.295704
=1.0496

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(140388.784 - 0 - 284619.397) / 2516208.197
=-0.057321

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

PT Darya-Varia Laboratoria Tbk has a M-score of -2.82 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.82 mean?
PT Darya-Varia Laboratoria Tbk (ISX:DVLA) has a Beneish M-Score of -2.82 as of Jun. 28, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors. According to the industry distribution chart, PT Darya-Varia Laboratoria Tbk ranks #220 out of 908 companies in the Drug Manufacturers industry, placing it in the top 24.2%.
Is PT Darya-Varia Laboratoria Tbk's Beneish M-Score too high?
PT Darya-Varia Laboratoria Tbk's current Beneish M-Score is -2.82. Based on the distribution chart, PT Darya-Varia Laboratoria Tbk ranks #220 out of 908 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, PT Darya-Varia Laboratoria Tbk has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Darya-Varia Laboratoria Tbk's Beneish M-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PT Darya-Varia Laboratoria Tbk ranks #220 out of 908 companies for Beneish M-Score. This places PT Darya-Varia Laboratoria Tbk in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors. PT Darya-Varia Laboratoria Tbk's current Beneish M-Score is -2.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Darya-Varia Laboratoria Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk (ISX:DVLA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp1,840.45, compared to a current price of Rp1,595.00 — trading 13.3% below its estimated fair value. The current Beneish M-Score is -2.82. PT Darya-Varia Laboratoria Tbk's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For PT Darya-Varia Laboratoria Tbk (ISX:DVLA), the current Beneish M-Score is -2.82 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk stock appears to be undervalued. The current stock price of Rp1,595.00 is trading 13.3% below its estimated GF Value™ of Rp1,840.45. GuruFocus considers PT Darya-Varia Laboratoria Tbk to be Modestly Undervalued.

Key valuation signals for ISX:DVLA:

  • Beneish M-Score: -2.82
  • GF Value™: Rp1,840.45 vs. price of Rp1,595.00 (13.3% below fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the ISX:DVLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Darya-Varia Laboratoria Tbk Business Description

Address Jalan. R.A. Kartini Kav. 8, 18th-19th Floor, South Quarter, Tower C, Jakarta, IDN, 12430
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is operating in the pharmaceutical industry. It is engaged in the manufacture and trade of pharmaceutical products, human, traditional medicines, pharmaceutical materials, raw materials for traditional medicines, inorganic base chemicals, organic base chemicals, equipment for surgery, medical and dental care, and equipment, orthopedic equipment, prosthetic, eyeglasses, laboratory and health equipment from glass, cosmetics, wholesaler of pharmaceutical, traditional medicine, chemical base materials, laboratory testing services, periodic inspection services, and many more activities. Its business segments include: prescription drugs; consumer health products, which derives key revenue; export and toll manufacturing services; and services.
73GF Score

Get the complete analysis for ISX:DVLA

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp1,595.00
Price
Rp1,840.45
GF Value